Affiliation:
1. Veterinary Teaching Hospital, Koret School of Veterinary Medicine The Hebrew University of Jerusalem Rehovot Israel
2. The American Medical Laboratories Herzliya Israel
Abstract
AbstractBackgroundHypothyroidism in dogs is associated with obesity and altered lipid and carbohydrate metabolism. The adipokines, visfatin, and betatrophin, affect glucose tolerance. Betatrophin is involved in lipid regulation.HypothesisVisfatin and betatrophin serum concentrations are altered in hypothyroid dogs.AnimalsDogs with naturally occurring hypothyroidism (n = 25) and healthy dogs (n = 25).MethodsInsulin, visfatin, and betatrophin serum concentrations were measured in all dogs and 19 of the hypothyroid dogs after 30 days of thyroxine treatment. Body condition score (BCS) was determined (1‐9 scale).ResultsVisfatin concentrations were lower in hypothyroid compared with healthy dogs (mean, 95% confidence interval [CI]; 2.0 ng/mL, 1.2‐3.3 vs 5.1 ng/mL, 3.3‐7.8; P = .004) and increased post‐treatment (3.1 ng/mL, 1.9‐4.9 vs 2.6 ng/mL, 1.6‐4.1; P = .05). Betatrophin concentrations were lower in lean to normal (body condition score [BCS], 3‐5) hypothyroid dogs compared to lean to normal healthy dogs (52 pg/mL, 9‐307 vs 597 pg/mL, 216‐1648; P = .03), but were not different between overweight (BCS, 6‐9) hypothyroid and healthy dogs (341 pg/L, 168‐695 vs 178 pg/mL, 77‐415; P = .26), and decreased post‐treatment in overweight dogs (206 pg/mL, 87‐488 vs 268 pg/mL, 112‐640; P = .004). Visfatin concentrations were higher in overweight compared with lean to normal dogs (4.7 ng/mL, 3.3‐6.6 vs 2.2 ng/mL, 1.2‐4.2; P = .04). Betatrophin concentrations were positively correlated with BCS (r = .47, P = .02) and insulin concentrations (r = .48, P = .03) in hypothyroid dogs and negatively correlated with BCS (r = −.47, P = .02) and thyroid stimulating hormone concentrations (r = −.56, P = .01) in healthy dogs.Conclusions and Clinical ImportanceHypothyroidism in dogs is associated with alterations in visfatin and betatrophin concentrations that partially resolve with thyroxine treatment.